The DOI matches its Crossref record; 273 of the 273 references it cites were found in a registry or an index.
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
Open accessAbstract
Antiepileptic drugs (AEDs) have many benefits but also many side effects, including aggression, agitation, and irritability, in some patients with epilepsy. This article offers a comprehensive summary of current understanding of aggressive behaviors in patients with epilepsy, including an evidence-based review of aggression during AED treatment. Aggression is seen in a minority of people with epilepsy. It is rarely seizure related but is interictal, sometimes occurring as part of complex psychiatric and behavioral comorbidities, and it is sometimes associated with AED treatment. We review the common neurotransmitter systems and brain regions implicated in both epilepsy and aggression, including the GABA, glutamate, serotonin, dopamine, and noradrenaline systems and the hippocampus, amygdala, prefrontal cortex, anterior cingulate cortex, and temporal lobes. Few controlled clinical studies have used behavioral measures to specifically examine aggression with AEDs, and most evidence comes from adverse event reporting from clinical and observational studies. A systematic approach was used to identify relevant publications, and we present a comprehensive, evidence-based summary of available data surrounding aggression-related behaviors with each of the currently available AEDs in both adults and in children/adolescents with epilepsy. A psychiatric history and history of a propensity toward aggression/anger should routinely be sought from patients, family members, and carers; its presence does not preclude the use of any specific AEDs, but those most likely to be implicated in these behaviors should be used with caution in such cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–273 of 273
Sokolov, B. P., & Cadet, J. L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300891 · Cited by 59
Monoamines, GABA, Glutamate, and Aggression
Miczek, K. A., & Fish, E. W. (2005) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195168761.003.0005 · Cited by 59
Preliminary efficacy and safety of lacosamide in children with refractory epilepsy
Heyman, E., Lahat, E., Levin, N., Berkovitch, M., & Gandelman‐Marton, R. (2011) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2011.08.007 · Cited by 58
A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy
Guerrini, R., Rosati, A., Segieth, J., Pellacani, S., Bradshaw, K., & Giorgi, L. (2013) · Epilepsia · doi:10.1111/epi.12233 · Cited by 57
Ciesielski, A.-S., Samson, S., & Steinhoff, B. J. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.07.011 · Cited by 57
Self-citationGavatha, M., Ioannou, I., & Papavasiliou, A. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.02.005 · Cited by 56
Anticonvulsant effect of intranigral fluoxetine
Pasini, A., Tortorella, A. A. V., & Gale, K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91320-e · Cited by 56
Seidenwurm, D. J., Pounds, T. R., Globus, A., et al. (1997) · PubMed · Cited by 56
The importance of being seizure free: topiramate and psychopathology in epilepsy
Mula, M., & Trimble, M. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00145-8 · Cited by 55
Self-citationStructural brain abnormalities in aggression and violent behavior
Bannon, S. M., Salis, K. L., & O’Leary, K. D. (2015) · Aggression and Violent Behavior · doi:10.1016/j.avb.2015.09.016 · Cited by 52
Clonazepam in the Treatment of Epilepsy
Mikkelsen, B. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500050008002 · Cited by 52
Ronen, G. M., Richards, J., Cunningham, C., Secord, M., & Rosenbloom, D. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200001390 · Cited by 50
The Episodic Dyscontrol Syndrome and Aggression
Elliott, F. A. (1984) · Neurologic Clinics · doi:10.1016/s0733-8619(18)31119-8 · Cited by 48
Lee, R., Petty, F., & Coccaro, E. F. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.04.004 · Cited by 48
Raol, Y. H., Zhang, G., Budreck, E. C., & Brooks‐Kayal, A. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.005 · Cited by 48
The anticonvulsant retigabine is a subtype selective modulator of GABA A receptors
Treven, M., Koenig, X., Assadpour, E., Gantumur, E., Meyer, C., Hilber, K., Boehm, S., & Kubista, H. (2015) · Epilepsia · doi:10.1111/epi.12950 · Cited by 48
Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy
Kim, J. S., Kim, H., Lim, B. C., Chae, J., Choi, J., Kim, K. J., Hwang, Y. S., & Hwang, H. Y. (2013) · Brain and Development · doi:10.1016/j.braindev.2013.07.003 · Cited by 48
Improved mood states with lamotrigine in patients with epilepsy
Cramer, J. A., Hammer, A. E., & Kustra, R. P. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.07.005 · Cited by 47
Striatal dopamine receptor binding in epileptic psychoses
RING, H. A., Trimble, M., Costa, D. C., Moriarty, J., Verhoeff, N. P. L. G., & Ell, P. J. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90003-5 · Cited by 47
Neuropsychiatric side effects related to treatment with felbamate
McConnell, H., Snyder, P. J., Duffy, J., Weilburg, J. B., Valeriano, J., Brillman, J., Cress, K., & Cavalier, J. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.3.341 · Cited by 44
Guerrini, R., Rosati, A., Bradshaw, K., & Giorgi, L. (2014) · Epilepsia · doi:10.1111/epi.12548 · Cited by 43
Epilepsy and serotonin (5HT): Variations of 5HT-related genes in temporal lobe epilepsy
Štefulj, J., Bordukalo-Nikšić, T., Hečimović, H., Demarin, V., & Jernej, B. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.060 · Cited by 41
Amiri, M., & Hansen, C. P. (2014) · Seizure · doi:10.1016/j.seizure.2014.08.009 · Cited by 40
Effects of NMDA receptor channel blockade on aggression in isolated male mice
Владимировна, Б. И., & Bespalov, A. (1999) · Aggressive Behavior · Cited by 40
The convulsant and anticonvulsant effects of phencyclidine (PCP) and PCP analogues in the rat
Leccese, A. P., Marquis, K. L., Mattia, A., & Moreton, J. E. (1986) · Behavioural Brain Research · doi:10.1016/0166-4328(86)90014-8 · Cited by 40
Lee, J., Song, H. S., Hwang, Y., Lee, H., Suh, C.-K., & Park, S.-P. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.3.128 · Cited by 40
Treatment of psychosis, aggression, and irritability in patients with epilepsy
Alper, K., Barry, J. J., & Balabanov, A. J. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5069(02)00500-5 · Cited by 39
Porter, R. J., Burdette, D. E., Gil‐Nagel, A., Hall, S. T., White, R., Shaikh, S., & DeRossett, S. E. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.03.010 · Cited by 38
Shehata, G. A. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5903 · Cited by 38
Desipramine enhances isolation-induced aggressive behavior in mice
Matsumoto, K., Cai, B., Satoh, T., Ohta, H., & Watanabe, H. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90416-y · Cited by 38
Topiramate-induced metabolic acidosis: report of two cases
Ko, C.-H., & Kong, C.-K. (2001) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162201001268 · Cited by 38
Temporal Lobe Epilepsy with Amygdala Enlargement: A Morphologic and Functional Study
Takaya, S., Ikeda, A., Mitsueda‐Ono, T., Matsumoto, R., Inouchi, M., Namiki, C., Oishi, N., Mikuni, N., Ishizu, K., Takahashi, R., et al. (2012) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2011.00694.x · Cited by 36
Familial increase in plasma glutamic acid in epilepsy
Janjua, N. A., Itano, T., Kugoh, T., Hosokawa, K., NAKANO, M., Matsui, H., & Hatase, O. (1992) · Epilepsy Research · doi:10.1016/0920-1211(92)90019-p · Cited by 36
Irritability: the forgotten dimension of female-specific mood disorders
Born, L., & Steiner, M. S. (1999) · Archives of Women s Mental Health · doi:10.1007/s007370050044 · Cited by 36
Lopes, M. W., Soares, F. M. S., de Mello, N., Nunes, J. C., de Córdova, F. M., Walz, R., & Leal, R. B. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0797-y · Cited by 35
Vogl, C., Tanifuji, S., Danis, B., Daniels, V., Foerch, P., Wolff, C., Whalley, B. J., Mochida, S., & Stephens, G. J. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12799 · Cited by 35
Episodic rage and aggression attributed to frontal lobe seizures
Gedye, A. (1989) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1989.tb01491.x · Cited by 35
Aggression in Children Treated with Clobazam for Epilepsy
Sheth, R. D., Goulden, K. J., & Ronen, G. M. (1994) · Clinical Neuropharmacology · doi:10.1097/00002826-199408000-00004 · Cited by 34
Neurology of Aggression and Episodic Dyscontrol
Elliott, F. A. (1990) · Seminars in Neurology · doi:10.1055/s-2008-1041282 · Cited by 32
Anti-epileptic therapy and behaviour disturbances in children
Domizio, S. D., Verrotti, A., Ramenghi, L. A., Sabatino, G., & Morgese, G. (1993) · Child s Nervous System · doi:10.1007/bf00306271 · Cited by 32
Self-reported aggressiveness during treatment with levetiracetam correlates with depression
Mula, M., Agrawal, N., Mustafa, Z., Mohanalingham, K., Cock, H. R., Lozsádi, D. A., & von Oertzen, T. J. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.03.018 · Cited by 31
Self-citationWieshmann, U. C., & Baker, G. A. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002564 · Cited by 31
Téllez‐Zenteno, J. F., Ladino, Pandya, N., & Vrbancic, M. I. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45370 · Cited by 30
A personological approach to the study of aggression
Caprara, G. V., Barbaranelli, C., & Comrey, A. L. (1992) · Personality and Individual Differences · doi:10.1016/0191-8869(92)90222-b · Cited by 29
Klehm, J., Thomé-Souza, S., Fernández, I. S., Bergin, A. M. R., Bolton, J. B., Harini, C., Kadish, N. E., Libenson, M. H., Peters, J. M., Poduri, A., et al. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.01.025 · Cited by 28
Clobazam for Intractable Pediatric Epilepsy
Sheth, R. D., Ronen, G. M., Goulden, K. J., Penney, S., & Bodensteiner, J. B. (1995) · Journal of Child Neurology · doi:10.1177/088307389501000306 · Cited by 26
Surgical treatment of intractable epilepsy associated with focal cortical dysplasia
Diaz, R. J., Sherman, E. M. S., & Hader, W. J. (2008) · Neurosurgical FOCUS · doi:10.3171/foc/2008/25/9/e6 · Cited by 25
The long‐term efficacy and safety of levetiracetam in a tertiary epilepsy centre
Kang, B. S., Moon, H. J., Kim, Y., Lee, S., Jung, K., Chu, K., & Lee, S. K. (2013) · Epileptic Disorders · doi:10.1684/epd.2013.0599 · Cited by 22
Lamotrigine improves aggression in patients with temporal lobe epilepsy
Kato, H., Fukatsu, N., Noguchi, T., Oshima, T., Tadokoro, Y., & Kanemoto, K. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.03.015 · Cited by 21
Reversible Lamotrigine-Induced Neurobehavioral Disturbances in Children With Epilepsy
Cárdenas, J. F., Rho, J. M., & Ng, Y. (2009) · Journal of Child Neurology · doi:10.1177/0883073809336874 · Cited by 20
Yamamoto, T., Pipo, J. R., Akaboshi, S., & Narai, S. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00177-2 · Cited by 19
Tiagabine in the Management of Postencephalitic Epilepsy and Impulse Control Disorder
Kaufman, K. R., Kugler, S. L., & Sachdeo, R. C. (2002) · Epilepsy & Behavior · doi:10.1006/ebeh.2002.0319 · Cited by 19
Kawai, H., Sarai, M., Motoyama, S., Ito, H., Takada, K., Harigaya, H., Takahashi, H., Hashimoto, S., Takagi, Y., Ando, M., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003474 · Cited by 19
Quality of life--a view from the playground.
Brown, S. W. (1994) · PubMed · Cited by 19
Liefferinge, J. V., Jensen, C., Albertini, G., Bentea, E., Demuyser, T., Merckx, E., Aronica, E., Smolders, I. J., & Massie, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.080 · Cited by 18
Tran, V., Hatalski, C. G., Yan, X., & Baram, T. Z. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00847.x · Cited by 18
Hanzel, T. E., Kalachnik, J. E., & Harder, S. R. (1992) · Research in Developmental Disabilities · doi:10.1016/0891-4222(92)90012-u · Cited by 16
MAOA knockout mice are more susceptible to seizures but show reduced epileptogenesis
Teskey, G. C., Radford, K. S., Seif, I., & Dyck, R. H. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.03.001 · Cited by 16
A new Italian instrument for the assessment of irritability in patients with epilepsy
Piazzini, A., Turner, K., Edefonti, V. C., Bravi, F., Canevini, M. P., & Ferraroni, M. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.04.051 · Cited by 16
Biomarker Identification in Psychiatric Disorders: From Neuroscience to Clinical Practice
Razafsha, M., Khaku, A. S., Azari, H., Alawieh, A. M., Behforuzi, H., Fadlallah, B. H., Kobeissy, F. H., Wang, K., & Gold, M. S. (2015) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000460620.87557.02 · Cited by 16
Valentı́n, A., Moran, N. F., Hadden, R. D. M., et al. (2009) · Seizure · doi:10.1016/j.seizure.2009.01.001 · Cited by 16
Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsies
Gobbi, G., Pini, A., Bertani, G., Menegati, E., Tiberti, A., Valseriati, D., Besana, D., Rasmini, P., Guerrini, R., Belmonte, A., et al. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00124-7 · Cited by 16
Self-citationAlterations in the distribution of GABAA receptorsin epilepsy
Houser, C. R., Zhang, N., & Peng, Z. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02833.x · Cited by 15
Hassel, B., Taubøll, E., Shaw, R. N., Gjerstad, L., & Dingledine, R. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02545.x · Cited by 15
Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox–Gastaut Syndrome
Paolicchi, J., Ross, G. S., Lee, D., Drummond, R., & Isojärvi, J. I. T. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.06.021 · Cited by 14
Psychopharmacologic Management of Aggression
Newman, W. J. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.08.009 · Cited by 14
Serotonin 1A receptor inhibits the status epilepticus induced by lithium-pilocarpine in rats
Yang, Y., Guo, Y. C., Kuang, Y., Wang, S., Jiang, Y., Ding, Y., Wang, S., & Ding, M. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1396-x · Cited by 13
Perampanel and Challenging Behaviour in Intellectual Disability and Epilepsy: A Management Dilemma
Dolton, E., & Choudry, A. (2014) · Case Reports in Psychiatry · doi:10.1155/2014/409209 · Cited by 12
Ethosuximide-induced mania in a 10-year-old boy
Chien, J. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.05.004 · Cited by 12
What is a recommended treatment for aggression in a patient with schizophrenia?
Gobbi, G., & Debonnel, G. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0338 · Cited by 9
Self-citationSide effects of clonazepam therapy.
Edwards, V. E. (1974) · PubMed · Cited by 8
Simeon, D., & Berlin, H. (2008) · doi:10.1002/9780470515167.ch80 · Cited by 5
Neurobiology of Aggression: Neuroimaging Findings
Soyka, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_29 · Cited by 2
Cited by
Levetiracetam Mechanisms of Action: From Molecules to Systems
Contreras-García, I. J., Cárdenas-Rodríguez, N., Romo-Mancillas, A., Bandala, C., Zamudio, S. R., Gómez-Manzo, S., Hernández-Ochoa, B., Mendoza-Torreblanca, J. G., & Pichardo-Macías, L. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040475 · Cited by 131
Levetiracetam and brivaracetam: A review of evidence from clinical trials and clinical experience
Steinhoff, B. J., & Staack, A. M. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419873518 · Cited by 99
Self-citationManchia, M., & Fanos, V. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.024 · Cited by 42
Involvement of the GABAA receptor α subunit in the mode of action of etifoxine
Mattei, C., Taly, A., Soualah, Z., Saulais, O., Henrion, D., Guérineau, N. C., Verleye, M., & Legros, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.034 · Cited by 26
Fukuyama, K., & Okada, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094473 · Cited by 22
Metadata
- Authors
- Brodie, M. J., Besag, F., Ettinger, A. B., Mula, M., Gobbi, G., Comai, S., Aldenkamp, A. P., & Steinhoff, B. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 68
- Issue
- 3
- Pages
- 563-602
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2367812079
- Cited by
- 288
- References
- 273
- FWCI
- 18.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.